TAGAP restrains myeloid and T cell activation in inflammatory bowel disease.

Saved in:
Bibliographic Details
Title: TAGAP restrains myeloid and T cell activation in inflammatory bowel disease.
Authors: Lin RC; Inflammation Research, Amgen Inc., South San Francisco, CA, United States., Shao Z; Inflammation Research, Amgen Inc., South San Francisco, CA, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Sep 22; Vol. 16, pp. 1641365. Date of Electronic Publication: 2025 Sep 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1641365